TRACE Study – Post-MI Heart Failure Risk (TRACE-inspired) Calculator

Clinical calculation support · Verify results before clinical use

Post-MI clinical assessment

Enter the patient’s clinical features to calculate an educational, heuristic feature count. This is not an official TRACE score and does not provide a validated probability of future heart failure.

Patient characteristics

Complete all fields using the stated units.

—Points
Recorded for completeness; sex does not alter this heuristic total.
Reset calculator

About this estimator

The TRACE (Trandolapril Cardiac Evaluation) trial studied trandolapril in patients with left ventricular systolic dysfunction after myocardial infarction. It reported reductions in mortality and progression to severe heart failure with treatment; it was not the source of the heuristic point weights implemented here. Read the original trial on PubMed.

Features included in this prototype

FeatureHeuristic rulePoints
Age65–74 years / ≥75 years+1 / +2
LVEF≤50%, with greater weight at ≤45% and ≤35%+1 to +4
Killip classClass II / III / IV+1 / +2 / +3
Systolic BP<100 mmHg+1
Heart rate≥100 beats/min+1
Creatinine≥1.5 or ≥2.0 mg/dL+1 / +2
DiabetesPresent+1
Anterior infarctionPresent+1

These weights are retained from the supplied prototype for transparency; they have not been established as a validated model.

Clinical use

Assess the patient’s actual haemodynamic status, symptoms and signs of heart failure, LV function, renal function, infarct characteristics, comorbidities, and evidence-based post-MI management needs. Consider validated prediction tools appropriate to the clinical question and population.

Evidence and references

Køber L, Torp-Pedersen C, Carlsen JE, et al.; TRACE Study Group.A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med. 1995;333(25):1670–1676.DOI: 10.1056/NEJM199512213332503 · PMID: 7477219
TRACE Study Group.Changes in absolute and relative importance in the prognostic value of left ventricular systolic function and congestive heart failure after acute myocardial infarction. TRACE Study Group. 1998.PubMed: PMID 9631965.

These publications provide context for post-MI LV dysfunction and outcomes. They do not validate this tool’s point weights or category boundaries.

Clinical disclaimer: Educational and prototyping use only. This is not an official TRACE score, has not undergone derivation or external validation, and must not be interpreted as an absolute probability of heart failure. The output should not independently guide treatment, disposition, or follow-up decisions.